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Abstract
Background: Increasing energy costs and environmental concerns have motivated engineering
microbes for the production of "second generation" biofuels that have better properties than
ethanol.
Results and conclusion: Saccharomyces cerevisiae was engineered with an n-butanol biosynthetic
pathway, in which isozymes from a number of different organisms (S. cerevisiae, Escherichia coli,
Clostridium beijerinckii, and Ralstonia eutropha) were substituted for the Clostridial enzymes and their
effect on n-butanol production was compared. By choosing the appropriate isozymes, we were able
to improve production of n-butanol ten-fold to 2.5 mg/L. The most productive strains harbored
the C. beijerinckii 3-hydroxybutyryl-CoA dehydrogenase, which uses NADH as a co-factor, rather
than the R. eutropha isozyme, which uses NADPH, and the acetoacetyl-CoA transferase from S.
cerevisiae or E. coli rather than that from R. eutropha. Surprisingly, expression of the genes encoding
the butyryl-CoA dehydrogenase from C. beijerinckii (bcd and etfAB) did not improve butanol
production significantly as previously reported in E. coli. Using metabolite analysis, we were able to
determine which steps in the n-butanol biosynthetic pathway were the most problematic and ripe
for future improvement.
Background
Soaring energy costs and increased awareness of global
warming have motivated production of renewable, bio-
mass-derived fuels and chemicals. The reasons for produc-
ing alternatives to ethanol, the current biofuel standard,
are numerous and clear: ethanol suffers from low energy
density, it is hydroscopic, it cannot be piped, and it is
costly to distill, an aspect that detracts from the total
energy output of its production. Ideally, biofuels will
require minimal energy to separate from fermentation
broths, be non-toxic to the host micro-organism, and be
efficiently produced from a variety of feedstocks [1]. Com-
pared to ethanol, n-butanol is more hydrophobic, has a
higher energy density, can be transported through existing
Published: 3 December 2008
Microbial Cell Factories 2008, 7:36 doi:10.1186/1475-2859-7-36
Received: 14 October 2008
Accepted: 3 December 2008
This article is available from: http://www.microbialcellfactories.com/content/7/1/36
© 2008 Steen et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 8
(page number not for citation purposes)
Microbial Cell Factories 2008, 7:36 http://www.microbialcellfactories.com/content/7/1/36pipeline infrastructure, and can be mixed with gasoline at
any ratio. Thus, n-butanol is a substantially better biofuel
than ethanol.
n-Butanol can be produced either chemically from petro-
leum or fermentatively in a variety of Clostridial species.
Advances in biotechnology and increased petroleum costs
have renewed interest in fermentative n-butanol produc-
tion, however, Clostridia are not ideal because of the rela-
tive lack of genetic tools to manipulate their metabolism,
their slow growth, their intolerance to n-butanol above 1–
2% and oxygen, and their production of butyrate, ace-
tone, and ethanol as byproducts. Thus, there is interest in
producing n-butanol in a more suitable industrial organ-
ism. Recently, two groups have re-constructed the n-buta-
nol pathway from Clostridia and measured n-butanol
production in Escherichia coli (~1 mM) [2,3]. We chose
Saccharomyces cerevisiae as a host for n-butanol production
because it is a genetically tractable, well-characterized
organism, the current industrial strain alcohol (ethanol)
producer, and it has been previously manipulated to pro-
duce other heterologous metabolites [4]. Since n-butanol
and ethanol only differ by two carbons, S. cerevisiae may
be able to tolerate high concentrations of n-butanol by the
same mechanisms it tolerates ethanol. Recently, S. cerevi-
siae has been demonstrated to have tolerance to n-buta-
nol [5]. Here we demonstrate the engineering of S.
cerevisiae for the production of n-butanol and provide
insight for the next steps in engineering by detection of
intermediate pathway metabolites.
Results and discussion
Expression of n-butanol pathway isozymes from a range of 
organisms in S. cerevisiae results in n-butanol production
The reactions and corresponding enzymes for n-butanol
production are outlined in Figure 1. As enzymes with the
same catalytic function from different organisms have dif-
ferent catalytic activity, ability to be expressed, solubility,
etc., we sought to test a number of candidates for each
reaction in the pathway. The genes encoding these
enzymes were cloned into two different plasmids (Figure
2 and Table 1) and transformed into S. cerevisiae BY4742.
The first set of strains, ESY2, ESY3, and ESY4, were engi-
neered with enzymes from Ralstonia eutropha (phaA and
phaB), Streptomyces collinus (ccr), Clostridium beijer-
inckii (crt and adhe2), E. coli (atoB), and S. cerevisiae
(ERG10) and only varied in the first committed step, the
thiolase (PhaA, AtoB, and ERG10). We tested the enzymes
from R. eutropha, because these enzymes have previously
been demonstrated to retain high activity for the produc-
tion of polyhydroxyalkanoates in E. coli [6]. The two
other thiolases were tested because ERG10 is the native
thiolase in S. cerevisiae, and AtoB has been successfully
used to overproduce acetoacetyl-CoA (AcAcCoA) in other
metabolic pathways [7]. These strains produced different
levels of n-butanol (Figure 3), the highest being ESY2 (1
mg/L), suggesting that PhaA is the best thiolase in this spe-
cific pathway configuration. From these strains, we con-
structed and tested strains with different enzyme
candidates for their ability to increase n-butanol produc-
tion (Table 1 and Figure 3).
The second set of strains was constructed to compare n-
butanol production using different isozymes for 3-
hydroxybutyryl-CoA (HbCoA) dehydrogenase, which
converts AcAcCoA into HbCoA. One of these isozymes
uses NADPH (PhaB) as a cofactor, whereas the other iso-
zyme uses NADH (Hbd) as a cofactor. As cells growing
under fermentative conditions generally have excess
NADH, Hbd might be preferred to PhaB [2]. Although
PhaA appeared to be the best thiolase based on the results
using the previous set of strains, it was unclear that PhaA
would function as well with HbCoA dehydrogenase as it
did with PhaB (given the context dependence of some
pathway configurations [8]). Thus, we tested Hbd with all
three thiolases. These strains, ESY5, ESY6, and ESY7, all
produced detectable levels of n-butanol, while ESY7
(ERG10, hbd) doubled the production of n-butanol over
the previously highest producing strain, ESY2 (phaA,
phaB), reaching 2.5 mg/L. It is difficult to attribute the
increase in production to one specific enzyme, because
ESY7 harbors a different thiolase (ERG10) and a different
HbCoA dehydrogenase (hbd) that utilizes NADH, com-
pared to ESY2. It is curious why the strain harboring PhaA
is not as productive with Hbd as it is with PhaB. It may be
that PhaA and PhaB have been optimized through evolu-
tion to work together to maximize production of polyhy-
droxybutyrate in R. eutropha. That the strain harboring
ERG10 and Hbd is the highest producer is not surprising
given that ERG10 is the native thiolase and Hbd uses
NADH, which should be in ample supply under fermen-
tation conditions.
The final strain (ESY11) was made to determine if an alter-
native butyryl-CoA (BtCoA) dehydrogenase, which was
previously shown to greatly increase n-butanol produc-
tion in E. coli [2], would improve n-butanol production
over that by ESY7. Surprisingly, expression of the C. beijer-
inckii bcd and etfAB (ESY11) did not improve n-butanol
production significantly. Notably, ESY11 was the second
highest n-butanol producer and compared to ESY7, only
differed in the BtCoA dehydrogenase.
In summary, the best strain, ESY7, produced 2.5 mg/L n-
butanol from 2% galactose as a carbon source. This strain
overexpressed the native thiolase (ERG10) and an HbCoA
dehydrogenase (Hbd) that utilized NADH, which the cell
should have in plentiful supply under fermentative condi-
tions. ESY7, which also harbored ccr, produced slightlyPage 2 of 8
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The n-butanol biosynthetic pathwayFigure 1
The n-butanol biosynthetic pathway. The enzymes in green are from Clostridium beijerinckii. Enzymes in black are 
from other organisms: AtoB, Escherichia coli; Erg10, S. cerevisiae; PhaA, Ralstonia eutropha; PhaB, Ralstonia eutropha; Ccr, Strepto-
myces collinus. Each enzyme candidate was evaluated in the pathway for n-butanol production (except thl, which is native to 
Clostridia).
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Representative plasmids used in this studyFigure 2
Representative plasmids used in this study. Plasmids were constructed by the SLIC method, previously described. They 
contain the 2μ origin of replication, LEU2D or HIS3 genes for selection, the GAL1 or GAL10 promoters, and the CYC1, ADH1, 
or PGK1 transcription terminators. The first three genes of the n-butanol pathway were placed on the pESC-LEU2D plasmid 











































Table 1: Strains used in this study
Name Genotype Reference
BY4742 Mat α; HIS3Δ1; LEU2Δ0; LYS2Δ0; URA3Δ0; YDR242w::kanMX4 [11]
ESY2 BY4742: pESC-phaA-phaB-crt-LEU2D + pESC-ccr-adhe2-HIS This study
ESY3 BY4742: pESC-atoB-phaB-crt-LEU2D + pESC-ccr-adhe2-HIS This study
ESY4 BY4742: pESC-ERG10-phaB-crt-LEU2D + pESC-ccr-adhe2-HIS This study
ESY5 BY4742: pESC-phaA-hbd-crt-LEU2D + pESC-ccr-adhe2-HIS This study
ESY6 BY4742: pESC-atoB-hbd-crt-LEU2D + pESC-ccr-adhe2-HIS This study
ESY7 BY4742: pESC-ERG10-hbd-crt-LEU2D + pESC-ccr-adhe2-HIS This study
ESY11 BY4742: pESC-ERG10-hbd-crt-LEU2D + pESC-etfA-etfB-bcd-adhe2-HIS This study
Microbial Cell Factories 2008, 7:36 http://www.microbialcellfactories.com/content/7/1/36more n-butanol than ESY11, which harbored bcd and
etfAB.
Analysis of intermediary metabolites
In an attempt to explain the differences in n-butanol pro-
duction by the various strains, we analyzed the pathway
intermediates. Previously, this analysis has proven to be
successful in interrogating and optimizing metabolic
pathways [9]. We developed a single LC-MS method to
monitor all of the metabolites in the n-butanol biosyn-
thetic pathway simultaneously. Detection of all the meta-
bolic standards was successful, while detection of
intermediates in cell extracts was successful for all inter-
mediates except AcAcCoA. Although we analyzed the met-
abolic pathway intermediate levels in all strains, we
present the results for strains ESY4, ESY7, and ESY11 only.
We chose ESY7 because it was the highest producer, ESY4
because it differed from ESY7 only in the HbCoA dehy-
drogenase (PhaB in ESY4 versus Hbd in ESY7) and yet dis-
played a 10-fold difference in n-butanol titers (Figure 4).
We chose ESY11 because it was the second highest pro-
ducer and differed from ESY7 only in the choice of BtCoA
dehydrogenase (Ccr in ESY7 and EtfAB/Bcd in ESY11).
At 24 h, the levels of AcCoA in strains ESY4 and ESY7 were
indistinguishable, while the levels of HbCoA and BtCoA
were higher in strain ESY7 than in ESY4, suggesting that
the Hbd enzymatic reaction had higher flux than the PhaB
enzymatic reaction. ESY11, which differs from ESY7 only
in the BtCoA dehydrogenase (Ccr in ESY7 versus EtfAB/
Bcd in ESY11), accumulated BtCoA, which suggests a bot-
tleneck at BtCoA. Increased expression of adhe2 in ESY11
could alleviate the accumulation of BtCoA and improve
the production of n-butanol, perhaps beyond that of
ESY7. Since the levels of the other pathway metabolites
were essentially indistinguishable between ESY4 and
ESY7, we conclude that production of HbCoA by 3-
hydroxybutyryl-CoA dehydrogenase is the rate-limiting
n-Butanol production from engineered S. cerevisiaeFig re 3
n-Butanol production from engineered S. cerevisiae. Symbols and strains: black squares, ESY7; empty squares, ESY11; 
black circles, ESY2; the rest of the samples all produced approximately the same amount of n-butanol and are indicated on the 
graph. Symbols and error bars represent the mean and standard deviation of triplicate cultures.Page 5 of 8
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context. Proteomics analysis showed that Hbd (in ESY7)
and PhaB (in ESY4) were expressed at equivalent levels
(data not shown). As such, the differences in the NADPH
and NADH levels may explain the higher production of n-
butanol by ESY7 relative to ESY4. Indeed, NADPH limita-
tion has been demonstrated for other pathways [10].
Additionally, there is slightly more BtCoA in ESY7 than in
ESY4, which may ultimately correspond to higher n-buta-
nol production by ESY7. Interestingly, BtCoA seems to
accumulate in all strains and suggests further engineering
of Adhe2 is necessary. In support of this claim, we ana-
lyzed the solubility of Adhe2 by western blot and found
the majority of the protein in the insoluble fraction (data
not shown). The trends in the levels of pathway interme-
diates between strains ESY7 and ESY4 were maintained
through 72 h. Furthermore, increased expression of crt
may alleviate the higher levels of HbCoA and create a
more balanced pathway.
Conclusion
Here we provide the first demonstration of n-butanol pro-
duction in S. cerevisiae to 2.5 mg/L and tested a variety of
isozymes for different reactions in the metabolic pathway.
There are a number of obstacles to overcome when
expressing heterologous biosynthetic pathways, including
enzyme choice, verification of gene expression, balancing
of metabolic pathway intermediates and protein levels,
and removal of competing pathways, all the while increas-
ing production and maintaining host organism viability.
We successfully demonstrated substitution of isozymes
and analysis of pathway intermediates and determined
potential engineering targets for increasing n-butanol bio-
synthesis. Comparison of our strain to the native n-buta-
nol producers, Clostridia (~10 g/L), or the recently
engineered E. coli strains (~0.5 g/L) provides a goal for
future n-butanol titer. Given the results presented above
and S. cerevisiae's other attributes–inherent tolerance to
solvents [5], widespread use for industrial production of
ethanol, and ability to withstand oxygen (as opposed to
Clostridia)–S. cerevisiae may be an ideal host for industrial
n-butanol production. While increases in product titer
will certainly be necessary, increases of this magnitude
and greater have precedence [4].
Methods
Chemicals
Ethyl acetate was purchased from Sigma-Aldrich (St.
Louis, MO). Complete Supplement Mixtures for formula-
tion of Synthetic Defined (SD) media were purchased
from Qbiogene (Irvine, CA). All other media components
were purchased from Sigma-Aldrich.
Strains and media
Clostridium beijerinckii NCIMB 8052 was purchased from
ATCC, catalog number 51743. E. coli strains DH10B and
DH5á were used for bacterial transformation and plasmid
amplification in the construction of the expression plas-
mids used in this study. The strains were cultivated at
37°C in Luria-Bertani medium with 100 mg L-1 ampicil-
lin. S. cerevisiae strain BY4742 [11], a derivative of S288C,
was used as the parent strain for all yeast strains. This
strain was grown in rich YPD medium at 30°C [12]. Engi-
neered yeast strains were grown in SD medium [12] with
leucine, uracil, histidine, and/or methionine dropped out
where appropriate. For induction of genes expressed from
the GAL1 and GAL10 promoters, S. cerevisiae strains were
grown in 2% galactose as the sole carbon source unless
otherwise indicated.
Plasmid construction
C. beijerinckii genes were cloned from genomic DNA: hbd
encodes 3-hydroxybutyryl-CoA dehydrogenase; crt, croto-
nase; bcd, butyryl-CoA dehydrogenase; and etfA &etfB,
two-electron transferring flavoproteins A & B. phaA and
phaB (Ralstonia eutropha), adhe2 (C. beijerinckii), and ccr
(Streptomyces collinus) were synthesized (Epoch Biolabs).
All genes were PCR amplified with Phusion polymerase
(New England Biolabs). Primers were designed to have
30-bp flanking regions homologous to the plasmid inser-
tion regions, either the gal1 or gal10 promoter and the
CYC1, ADH1, or PGK1 terminator. Plasmid construction
was carried out using the Sequence and Ligation Inde-
pendent Cloning (SLIC) method, previously described
[13]. The constructed plasmids were derived from pADS-
AMO-CPR-opt-LEU2D plasmid [14] and pESC-HIS (Strat-
agene).
Yeast transformation and strain construction
Transformation of all S. cerevisiae strains was performed
using the lithium acetate method [15]. Strains ESY1-11
were constructed by the co-transformation of the indi-
cated plasmids followed by selection on SD-LEU or SD-
LEU-HIS plates as appropriate.
Yeast cultivation
All optical density measurements at 600 nm (OD600) were
taken using a Beckman DU-640 spectrophotometer. To
measure n-butanol production, culture tubes containing 5
mL of SD (2% galactose) medium (with appropriate
amino acid omissions as described above) were inocu-
lated with the strains of interest. These innocula were
grown at 30°C to an OD600 between 1 and 2. Capped
serum vials (100 mL) containing 50 mL SD medium were
inoculated to an OD600 0.05 with these seed cultures in
order to achieve a "semi" anaerobic condition. Samples
were collected at 24, 72, 120, and 144 h and analyzed for
metabolites as discussed below.
Metabolite detection
For metabolite analysis, cultures were sampled (10 mL) at
24, 72, 120, and 144 h. For n-butanol detection, 2 mLPage 6 of 8
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n-Butanol pathway intermediates at 24 hFig re 4
n-Butanol pathway intermediates at 24 h. Bars and strains: black bars, ESY4; gray bars, ESY7; white bars, ESY11. (A) All 
pathway intermediates in strains ESY4, 7 and 11. (B) HbCoA, CrCoA and BtCoA intermediates in strains ESY4 and ESY7. Lev-
els of AcCoA were similar except for strains ESY11 (A). Levels of 3-hydroxybutyryl-CoA (HbCoA) and butyryl-CoA (BtCoA) 
were notably higher in ESY7 compared to ESY4, while crotonyl-CoA (CrCoA) was relatively similar in the two strains. Values 
and error bars represent the mean and standard deviation of triplicate cultures.
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ethyl acetate containing n-pentanol (0.005% v/v), an
internal standard, was added to the 10 mL sample and
vortexed for 1 min. The ethyl acetate was then recovered
and applied to a Thermo Trace Ultra gas chromatograph
(GC) equipped with a Triplus AS autosampler and a TR-
WAXMS column (Thermo Scientific). The samples were
run on the GC with the following program: initial temper-
ature, 40°C for 1.2 min, ramped to 130°C at 25°C/min,
ramped to 220°C at 35°C/min. Final quantification anal-
ysis was achieved with Xcalibur software. For pathway
intermediate analysis, a method previously established
was employed [16]. Specifically, 10-mL samples were pel-
leted (6000 rpm, 5 min, 4°C). The supernatant was aspi-
rated, and the cells were suspended in 1 mL of 10% TCA
containing propionyl-CoA (10 μM) as an internal stand-
ard. The cells were bead-beaten for 4 min. The supernatant
was collected and neutralized with 2× volume of 1 M
octylamine. Samples were then filtered and separated on
a Zorbax 300SB-C1 8 column (Agilent; 2.1 mm i.d. × 10
cm length) using an Agilent 1100 series HPLC at a flow
rate of 150 μL/min. The LC conditions used were adapted
from Pitera et al. [9] Briefly, samples were run from initial
conditions of t = 0 min in 95% 100 mM ammonium ace-
tate (Buffer A), 5% 100 mM ammonium acetate:ace-
tonitrile (70%:30%) (Buffer B); t = 5 min, 95% Buffer A,
5% Buffer B; t = 12 min, 80% Buffer A, 20% Buffer B; t =
16 min, 10% Buffer A, 90% Buffer B; t = 25 min, 10%
Buffer A, 90% Buffer B; t = 28 min, 95% Buffer A, 5%
Buffer B; t = 45 min, 95% Buffer A, 5% Buffer B. The LC
system was interfaced to an Applied Biosystems Q TRAP
2000 LC/MS/MS via a Turbo Ionspray source operating in
the positive ion mode (5500 V). The MS was operated in
single-ion-monitoring (SIM) mode with a dwell time of
200 ms for each CoA metabolite of interest. Data were col-
lected and analyzed with Analyst™ 1.4.2 (Applied Biosys-
tems).
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